The Editorial Position on 'Recent Advances in Multifunctional Antimicrobial Peptides as Preclinical Therapeutic Studies and Clinical Future Applications'.


Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
26 Sep 2023
Historique:
received: 13 09 2023
accepted: 16 09 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

Antibiotic resistance has recently been recognized as an alarming issue and one of the leading causes of death worldwide [...].

Identifiants

pubmed: 37896143
pii: pharmaceutics15102383
doi: 10.3390/pharmaceutics15102383
pmc: PMC10609690
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

Pharmaceutics. 2023 May 01;15(5):
pubmed: 37242633
Pharmaceutics. 2022 Oct 26;14(11):
pubmed: 36365116
Sci Rep. 2017 Nov 9;7(1):15199
pubmed: 29123174
Pharmaceutics. 2022 Dec 04;14(12):
pubmed: 36559210
Bioengineering (Basel). 2023 Feb 06;10(2):
pubmed: 36829708
Adv Healthc Mater. 2015 Sep 16;4(13):2026-36
pubmed: 26379222
Pharmaceutics. 2023 May 20;15(5):
pubmed: 37242791
Ann N Y Acad Sci. 2003 May;992:168-78
pubmed: 12794056
Theranostics. 2020 May 15;10(14):6167-6181
pubmed: 32483446
Trends Microbiol. 2003 Dec;11(12):585-92
pubmed: 14659691
Pharmaceutics. 2022 Sep 12;14(9):
pubmed: 36145669
Int J Biochem Cell Biol. 2018 Nov;104:133-137
pubmed: 30236992
Pharmaceutics. 2022 Sep 19;14(9):
pubmed: 36145725
Regul Pept. 2005 Jan 15;124(1-3):27-35
pubmed: 15544838
Shock. 2018 May;49(5):522-528
pubmed: 29049134
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
PLoS One. 2015 Dec 14;10(12):e0145143
pubmed: 26659616
Lancet Microbe. 2023 Mar;4(3):e179-e191
pubmed: 36736332
PLoS One. 2013 Jul 24;8(7):e68993
pubmed: 23894389
Pharmaceutics. 2022 Dec 26;15(1):
pubmed: 36678702
Pharmaceutics. 2022 Sep 22;14(10):
pubmed: 36297449
Cell Mol Neurobiol. 1998 Apr;18(2):249-66
pubmed: 9535293
Pharmaceutics. 2022 Dec 22;15(1):
pubmed: 36678669
Front Immunol. 2022 Sep 29;13:985472
pubmed: 36248786
Pharmaceutics. 2022 Dec 01;14(12):
pubmed: 36559166
Liver Int. 2019 Feb;39(2):299-306
pubmed: 30261128
Front Immunol. 2022 Aug 25;13:977175
pubmed: 36090980
Cell Mol Life Sci. 2005 Feb;62(3):377-85
pubmed: 15723172
Cell Mol Life Sci. 2007 Nov;64(22):2863-86
pubmed: 17717629
Pharmaceutics. 2023 Jan 12;15(1):
pubmed: 36678901
Lancet Infect Dis. 2020 Sep;20(9):e216-e230
pubmed: 32653070
Pharmaceutics. 2022 Oct 12;14(10):
pubmed: 36297613
FEBS Lett. 1982 Jun 1;142(1):107-10
pubmed: 7049727
Pharmaceutics. 2022 Nov 22;14(12):
pubmed: 36559048

Auteurs

Francesco Scavello (F)

IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.

Mohamed Amiche (M)

Laboratoire de Biogenèse des Signaux Peptidiques (BioSiPe), Institut de Biologie Paris-Seine, Sorbonne Université-CNRS, 75252 Paris, France.

Jean-Eric Ghia (JE)

Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
Section of Gastroenterology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.

Classifications MeSH